The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK-Reference-Cited by-同舟云学术

The alarmin S100A9 hampers osteoclast differentiation from human circulating precursors by reducing the expression of RANK

Published:2019-06-14 Issue:9 Volume:33 Page:10104-10115
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Di Ceglie Irene¹,Blom Arjen B.¹,Davar Robab²,Logie Colin²,Martens Joost H. A.²,Habibi Ehsan²,Böttcher Lisa‐Marie¹,Roth Johannes³,Vogl Thomas³,Goodyear Carl S.⁴,Kraan Peter M.¹,Lent Peter L.¹,Bosch Martijn H.¹

Affiliation:

1. Experimental RheumatologyRadboud University Medical Center Nijmegen The Netherlands

2. Department of Molecular BiologyFaculty of ScienceRadboud University Nijmegen The Netherlands

3. Institute of ImmunologyUniversity of Münster Münster Germany

4. Institute of Infection, Immunity and InflammationUniversity of Glasgow Glasgow United Kingdom

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802691RR

Reference50 articles.

1. Osteoclast differentiation and activation

2. Osteoclasts: What Do They Do and How Do They Do It?

3. Bone Resorption by Osteoclasts

4. Regulation of Osteoclast Differentiation by Cytokine Networks

5. Inflammation, cancer, and bone loss

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis;Current Issues in Molecular Biology;2024-04-19

2. S100A8/A9 drives monocytes towards M2-like macrophage differentiation and associates with M2-like macrophages in osteoarthritic synovium;Rheumatology;2024-01-12

3. Plumbagin modulates RANKL-induced osteoclast and osteoblast differentiation;Phytomedicine Plus;2023-05

4. CYP27A1 deficiency promoted osteoclast differentiation;PeerJ;2023-03-03

5. Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma;Journal for ImmunoTherapy of Cancer;2023-01